Comparison of Electroacupuncture and Moxibustion for Relieving Visceral Hypersensitivity in Rats with Constipation-Predominant Irritable Bowel Syndrome

被引:6
|
作者
Zhao, Ji-Meng [1 ]
Chen, Liu [1 ]
Zhou, Ci-Li [2 ]
Shi, Yin [1 ,2 ]
Li, Yu-Wei [1 ]
Shang, Hai-Xia [1 ]
Wu, Lu-Yi [1 ]
Bao, Chun-Hui [2 ]
Dou, Chuan-Zi [2 ]
Wu, Huan-Gan [1 ,2 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shanghai 201203, Peoples R China
[2] Shanghai Inst Acupuncture Moxibust & Meridian, Shanghai 200030, Peoples R China
基金
中国国家自然科学基金;
关键词
5-HT4; RECEPTOR; MAST-CELLS; SEROTONIN; DIARRHEA;
D O I
10.1155/2016/9410505
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Aim. To compare whether there is different effect between electroacupuncture (EA) and moxibustion (Mox) on visceral hypersensitivity (their analgesic effects) in constipation-predominant irritable bowel syndrome (C-IBS). Methods. EA at 1 mA and 3 mA and Mox at 43 degrees C and 46 degrees C were applied to the Shangjuxu (ST37, bilateral) acupoint in rats with C-IBS and normal rats. An abdominal withdrawal reflex (AWR) score was used to assess visceral hypersensitivity. Toluidine blue staining was used to assess mast cell (MC) activity in colon of rats. Immunochemistry was used to measure 5-HT and 5-HT4 receptor expression in the colon. Results. AWR scores in all EA (1 mA and 3 mA) and Mox (43 degrees C and 46 degrees C) treatment groups after colorectal distention (CRD) stimulation pressure of 20, 40, 60, and 80 mm Hg were significantly lower than those of the model (MC) group (P all < 0.01). The MC counts and degranulation rates in the colon of all EA and Mox treatment groups and the MC group were significantly higher than those of the NC group (P all < 0.01). MC degranulation rates in the colon of all EA and Mox treatment groups were lower than those of the MC group (P all < 0.05). 5-HT expression in colon of all EA and Mox treatment groups was significantly lower than that of the MC group (P all < 0.01), and 5-HT4R expression in colon of both EA groups was significantly higher than that of the MC group (P both < 0.01). Conclusion. EA andMox treatments may both ameliorate visceral hypersensitivity at different degree in rats with C-IBS, and EA treatment was better than Mox.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Increased β-Adrenergic Sensitivity Correlates with Visceral Hypersensitivity in Patients with Constipation-Predominant Irritable Bowel Syndrome
    Jung Ho Park
    Poong-Lyul Rhee
    Hyun Seo Kim
    Jun Haeng Lee
    Young-Ho Kim
    Jae Jun. Kim
    Jong Chul Rhee
    Eun Ho Kang
    Bum-Hee Yu
    Digestive Diseases and Sciences, 2005, 50 (8) : 1 - 1
  • [2] Increased β-Adrenergic Sensitivity Correlates with Visceral Hypersensitivity in Patients with Constipation-Predominant Irritable Bowel Syndrome
    Jung Ho Park
    Poong-Lyul Rhee
    Hyun Seo Kim
    Jun Haeng Lee
    Young-Ho Kim
    Jae Jun. Kim
    Jong Chul Rhee
    Eun Ho Kang
    Bum-Hee Yu
    Digestive Diseases and Sciences, 2005, 50 : 1454 - 1460
  • [3] Increased β-adrenergic sensitivity correlates with visceral hypersensitivity in patients with constipation-predominant irritable bowel syndrome
    Park, JH
    Rhee, PL
    Kim, HS
    Lee, JH
    Kim, YH
    Kim, JJ
    Rhee, JC
    Kang, EH
    Yu, BH
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (08) : 1454 - 1460
  • [4] Tenapanor for constipation-predominant irritable bowel syndrome
    Siddiqui, S.
    Cash, B. D.
    DRUGS OF TODAY, 2020, 56 (03) : 203 - 210
  • [5] LubiprostoneIn Constipation-Predominant Irritable Bowel Syndrome
    Natalie J. Carter
    Lesley J. Scott
    Drugs, 2009, 69 : 1229 - 1237
  • [6] Lubiprostone In Constipation-Predominant Irritable Bowel Syndrome
    Carter, Natalie J.
    Scott, Lesley J.
    DRUGS, 2009, 69 (09) : 1229 - 1237
  • [7] Tegaserod for constipation-predominant irritable bowel syndrome
    Kale-Pradhan, Pramodini B.
    Wilhelm, Sheila M.
    PHARMACOTHERAPY, 2007, 27 (02): : 267 - 277
  • [8] Diarrhea- and constipation-predominant irritable bowel syndrome
    Richard Lea
    Peter J. Whorwell
    Current Treatment Options in Gastroenterology, 2001, 4 (4) : 299 - 308
  • [9] Polyethylene Glycol in Constipation-Predominant Irritable Bowel Syndrome
    Shearer, Jessica
    Ford, Alexander C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (01): : 135 - 135
  • [10] Antibiotic Treatment of Constipation-Predominant Irritable Bowel Syndrome
    Mark Pimentel
    Christopher Chang
    Kathleen Shari Chua
    James Mirocha
    John DiBaise
    Satish Rao
    Meridythe Amichai
    Digestive Diseases and Sciences, 2014, 59 : 1278 - 1285